Layoffs Ahead As Johnson & Johnson Retools Diabetes Unit

Published: Nov 14, 2013

Johnson & Johnson is planning job cuts but others are hiring too! Check it out! (Isn't it tempting?)

Johnson & Johnson officials reveal to plans to restructure its diabetes division to "get in front" of pricing and reimbursement pressures, saying an unspecified number of layoffs will occur. Johnson & Johnson (NYSE:JNJ) told today that it plans to make an unspecified number of job cuts, consolidate facilities and change the reporting structure on some of the sales units within its diabetes unit to "get in front" of pricing and reimbursement pressures. David Detmers, director of communications for Johnson & Johnson's diabetes solutions business, told us that the company made an internal announcement to employees this week.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)

Back to news